|
|
Novo Nordisk A/S CDR
TSX •
Healthcare •
Drug Manufacturers - General •
Quote as of 10/27/2026 15:21
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeTSX
Market Capitalization74,826 mln
Float3,166 mln
Earnings Date11/04/2026
Key Fundamentals
EPS1.77
P/E9.53
ROE60.88
ROIC21.47
ROA21.63
Interest Cover29.90
EBITDA, mln35,728
EV / EBITDA6.98
EV / EBIT7.90
Revenue, mln70,946
EV / Revenue3.69
Quote Details
Last
16.87
Change
-0.25 (-1.46%)
Open
16.97
Volume
5,589
Turnover
94,286
Average Volume
11,180
Financial Ratios
Pre-Tax Profit Margin45
Leverage Ratio2.69
Current Ratio0.87
Price / Book5.03
Price / Tangible Book11.16
Price / Cash Flow8.66
Price / Free Cash Flow14.99
Debt / Equity0.63
Price / Sales3.40
PEG Ratio0.38
Financial Strength
Altman Z-Score3.66
Piotroski F-Score
5
/ 9
Beneish M-Score-2.33
Price to Intrinsic Value1.20
Price to Lynch Fair Value0.43
Price to Graham Number2.31
Shiller PE Ratio16.62
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
-1.29% |
26
/ 100
 |
| 1 Month |
1.38% |
72
/ 100
 |
| 2 Months |
-19.6% |
6
/ 100
 |
| 6 Months |
-0.55% |
36
/ 100
 |
|
| |
